- 47.4% of participants used GHB/GBL in the past year; 72.9% were occasional users and 27.1% were frequent users.
- Frequent users reported more adverse events, including unconsciousness and overdose, and screened higher for problematic use.
- Higher GHB/GBL frequency linked to methamphetamine, research chemical and benzodiazepine use, and findings urge inclusive harm reduction beyond MSM/chemsex.
Subst Use Misuse. 2026 Aug 11:1-10. doi: 10.1080/10826084.2026.2704629. Online ahead of print.
ABSTRACT
Introduction: Gamma-hydroxybutyric acid (GHB) and its precursor gamma-butyrolactone (GBL) are psychoactive substances commonly associated with men who have sex with men (MSM) and sexualized substance use contexts. Large-scale studies exploring broader sociodemographic characteristics and substance use behaviors among GHB/GBL users remain scarce. Methods: A convenience sample was recruited online through nightlife contexts to complete an anonymous online-questionnaire with a one-year follow-up. The survey assessed sociodemographic data, use of GHB/GBL and other psychoactive substances, GHB/GBL-related adverse events, and lifetime psychiatric diagnosis. Participants were categorized as occasional or frequent users based on the past 12 months. Results: Among 2196 participants, 47.4% reported GHB/GBL use within the past year; among these, 72.9% were occasional users (< 1x/week), and 27.1% frequent users (≥ 1x/week). At one-year follow-up, 10.9% of the sample was retained. The majority of users were male, with 40% of frequent users and 42% of occasional users identifying as homosexual. Frequent users reported more negative events associated with use (e.g., unconsciousness and overdose) and screened more often for problematic use (CAGE-AID). GHB/GBL use frequency was positively associated with methamphetamine, research chemical, and benzodiazepine use, and negatively associated with alcohol use. Conclusions: This study provides insight into GHB use in a diverse sample and confirms higher levels of adverse effects and problematic use patterns among frequent users. Findings highlight the need for prevention and harm reduction strategies that go beyond MSM/chemsex contexts. Broader, inclusive public health approaches are essential to reduce risks and address the evolving landscape of GHB use.
PMID:42581015 | DOI:10.1080/10826084.2026.2704629
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
